Jose Luis Casado
Overview
Explore the profile of Jose Luis Casado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saavedra C, Vallejo A, Longo F, Serrano J, Fernandez M, Gion M, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046661
Few data are available about the immune response to mRNA SARS-CoV-2 vaccines in patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors (CDK4/6i). We conducted a prospective, single-center study of...
2.
Vivancos-Gallego M, Sanchez-Conde M, Rodriguez-Dominguez M, Fernandez-Gonzalez P, Martinez-Garcia L, Garcia-Mouronte E, et al.
Open Forum Infect Dis
. 2022 Nov;
9(11):ofac557.
PMID: 36381620
We describe the first 25 persons with HIV diagnosed with human monkeypox virus (MPXV) in our hospital in an ongoing outbreak in Spain. Proctitis was the predominant finding in 52%,...
3.
Vallejo A, Vizcarra P, Quereda C, Moreno A, Casado J
Eur J Clin Invest
. 2021 Jun;
51(12):e13636.
PMID: 34164811
Background: Healthcare workers (HCWs) are at increased risk since they are directly exposed to SARS-CoV-2-infected patients, and nevertheless, some remain without the development of anti-SARS-CoV-2 antibodies or related symptoms, suggesting...
4.
Castro-Granell V, Garin N, Jaen A, Casado J, Leal L, Cenoz S, et al.
AIDS Behav
. 2021 May;
25(12):3883-3897.
PMID: 33932187
We analysed the impact of recreational drug use (RDU) on different outcomes in people living with HIV (PLHIV). A multicentre retrospective cohort study was performed with two cohorts of PLHIV...
5.
Navarro J, Gonzalez-Cordon A, Casado J, Bernardino J, Domingo P, Portilla J, et al.
J Antimicrob Chemother
. 2020 Mar;
75(7):1955-1960.
PMID: 32134108
Background: The combination of boosted darunavir plus rilpivirine, once daily, could be a convenient, effective and well-tolerated two-drug regimen to achieve HIV suppression in HIV-infected patients. Methods: Multicentre, retrospective cohort...
6.
Dolengevich-Segal H, Gonzalez-Baeza A, Valencia J, Valencia-Ortega E, Cabello A, Tellez-Molina M, et al.
PLoS One
. 2019 Dec;
14(12):e0220272.
PMID: 31800575
Objectives: Sexualized intravenous drug use, also known as slamsex, seems to be increasing among HIV-positive men who have sex with men (MSM). Physical and psychopathological symptoms have previously been reported...
7.
Gorospe L, Casado J, Serrano-Villar S, de la Puente-Bujidos C, Perez-Elias M, Vivancos-Gallego M
J Clin Rheumatol
. 2019 Nov;
25(8):e132.
PMID: 31764500
No abstract available.
8.
Gomez-Ayerbe C, Martinez-Sanz J, Muriel A, Perez Elias P, Moreno A, Barea R, et al.
PLoS One
. 2019 Aug;
14(8):e0220375.
PMID: 31369594
Introduction: HIV testing guidelines are poorly implemented in most clinical settings. The best screening strategy and healthcare scenario are still unknown. The aim of our study is to evaluate the...
9.
Casado J, Fontecha M, Monsalvo M, Vizcarra P
Enferm Infecc Microbiol Clin (Engl Ed)
. 2018 Dec;
36 Suppl 2:31-36.
PMID: 30545470
Because lifelong therapy is needed in HIV infection, high long-term adherence is necessary. Darunavir/co-bicistat/emtricitabina/tenofovir alafenamide (Symtuza) is the first triple therapy combining a protease inhibitor (PI) in a single tablet...
10.
Gonzalez-Baeza A, Dolengevich-Segal H, Perez-Valero I, Cabello A, Jesus Tellez M, Sanz J, et al.
AIDS Patient Care STDS
. 2018 Apr;
32(3):112-118.
PMID: 29620925
The magnitude of sexualized drug use (SDU), also known as chemsex, and its association with sexually transmitted infections (STI) has not been systematically explored in HIV-positive patients. This study aimed...